Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in EOCN — Galmed Pharmaceuticals Ltd.

CIK 72971 SAN FRANCISCO, CA
Back to EOCN Full portfolio

Position in EOCN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2
+$2 QoQ
Shares Held
43
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 12 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. EOCN ranks #409 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in EOCN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2 43
2026-03-31 — 43
2025-12-31 — 9
2025-09-30 — 9
2025-06-30 — 9
2025-03-31 — 9
2024-12-31 — 18
2024-09-30 — 18
2024-06-30 — 204
2024-03-31 — 204
2023-12-31 — 204
2023-09-30 — 204
2023-06-30 — 204
2023-03-31 — 3,050
2022-12-31 — 3,050
2022-09-30 — 4,050
2022-06-30 — 6,330
2022-03-31 — 6,330
2021-12-31 — 6,330
2021-09-30 — 6,330
2021-06-30 — 6,330
2021-03-31 — 6,330
2020-12-31 — 6,330
2020-09-30 — 6,330
2020-06-30 — 6,330
2020-03-31 — 6,330